Bio-Techne (TECH) Other Non-Current Liabilities (2014 - 2026)
Bio-Techne (TECH) recorded quarterly Other Non-Current Liabilities of $21.7 million in Q1 2026, down 6.11% quarter-over-quarter from $23.1 million in Q4 2025, and up 38.4% on a YoY basis from $15.7 million in Q1 2025.
Bio-Techne (TECH) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
Bio-Techne's Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $21.7 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 38.4% year-over-year to $21.7 million; the TTM figure through Mar 2026 stood at $21.7 million (up 38.4% YoY), while the FY2025 annual figure was $27.1 million, up 105.84% from the prior year.
- Other Non-Current Liabilities was $21.7 million for Q1 2026 at Bio-Techne, down from $23.1 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $27.1 million in Q2 2025 to a low of $4.8 million in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $14.8 million across 5 years, with a median of $12.2 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities tumbled 40.41% in 2022, then surged 148.01% in 2023.
- A 5-year view of Other Non-Current Liabilities shows it stood at $7.0 million in 2022, then surged by 148.01% to $17.4 million in 2023, then tumbled by 34.7% to $11.3 million in 2024, then surged by 103.56% to $23.1 million in 2025, then dropped by 6.11% to $21.7 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $21.7 million (Q1 2026), $23.1 million (Q4 2025), and $23.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.67 Mn |
| Dec 31, 2025 | 23.08 Mn |
| Sep 30, 2025 | 23.81 Mn |
| Jun 30, 2025 | 27.08 Mn |
| Mar 31, 2025 | 15.66 Mn |
| Dec 31, 2024 | 11.34 Mn |
| Sep 30, 2024 | 19.79 Mn |
| Jun 30, 2024 | 13.16 Mn |
| Mar 31, 2024 | 11.56 Mn |
| Dec 31, 2023 | 17.36 Mn |
| Sep 30, 2023 | 9.39 Mn |
| Jun 30, 2023 | 10.92 Mn |
| Mar 31, 2023 | 10.97 Mn |
| Dec 31, 2022 | 7.00 Mn |
| Sep 30, 2022 | 11.50 Mn |
| Jun 30, 2022 | 12.24 Mn |
| Mar 31, 2022 | 4.80 Mn |
| Dec 31, 2021 | 11.75 Mn |
| Sep 30, 2021 | 17.60 Mn |
| Jun 30, 2021 | 18.30 Mn |